v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Components of Income (Loss) Before Income Taxes

For the years ended December 31, 2023 and 2024, income (loss) before income taxes includes the following components (in thousands):

 

 

Years ended December 31,

 

 

 

2023

 

 

2024

 

 

 

(Restated)

 

 

 

 

United States

 

$

4,187

 

 

$

(8,245

)

Foreign

 

 

(60,799

)

 

 

(68,061

)

Loss before income taxes

 

$

(56,612

)

 

$

(76,306

)

 

 

 

 

 

 

 

Schedule of (Benefit) Provision of Income Taxes

For the years ended December 31, 2023 and 2024, the provision for income taxes consists of the following (in thousands):

 

 

 

Years ended December 31,

 

 

 

2023

 

 

2024

 

 

 

(Restated)

 

 

 

 

Current:

 

 

 

 

 

 

U.S. federal

 

$

3,647

 

 

$

(3,801

)

State

 

 

154

 

 

 

(478

)

Foreign

 

 

885

 

 

 

917

 

Current tax provision (benefit)

 

 

4,686

 

 

 

(3,362

)

Deferred:

 

 

 

 

 

 

U.S. federal

 

$

5,820

 

 

$

 

State

 

 

844

 

 

 

 

Foreign

 

 

6,118

 

 

 

1,508

 

Deferred tax provision

 

 

12,782

 

 

 

1,508

 

Provision (benefit) for income taxes

 

$

17,468

 

 

$

(1,854

)

 

 

 

 

 

 

 

Computation of (Benefit) Provision of Income Taxes Reconciliation The table below reconciles the Company's tax (benefit) provision for income taxes based on the statutory U.S. federal income tax rate to its effective tax rate for the years ended December 31, 2023 and 2024 (in thousands):

 

 

 

Years ended December 31,

 

 

 

 

2023

 

 

2024

 

 

 

 

(Restated)

 

 

 

 

Income tax benefit at federal statutory rate

 

 

$

(11,889

)

 

$

(16,024

)

State and local income taxes, net of federal benefit on current year earnings

 

 

 

154

 

 

 

68

 

Tax rate changes

 

 

 

(1,255

)

 

 

 

Valuation allowance changes

 

 

 

37,283

 

 

 

12,345

 

Foreign rate differential

 

 

 

(1,665

)

 

 

(2,454

)

Withholding tax on non-permanent investment in subsidiaries

 

 

 

 

 

 

1,508

 

Research and development

 

 

 

(2,385

)

 

 

(278

)

Share-based compensation

 

 

 

311

 

 

 

1,203

 

Foreign derived intangible income

 

 

 

(2,887

)

 

 

(199

)

Return to provision and impact of method change (Federal, State and Foreign)

 

 

 

 

 

 

2,730

 

Tax expense related to impairment

 

 

 

 

 

 

25

 

Other

 

 

 

(199

)

 

 

(778

)

Provision (benefit) for income taxes

 

 

$

17,468

 

 

$

(1,854

)

 

 

 

 

 

 

 

 

Schedule of Deferred Tax Assets and Liabilities

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities at December 31, 2023 and 2024 were as follows (in thousands):

 

 

Years ended December 31,

 

 

 

2023

 

 

2024

 

 

 

(Restated)

 

 

 

 

Net operating losses

 

$

19,880

 

 

$

37,162

 

Tax credit carryforwards

 

 

2,867

 

 

 

4,192

 

Capitalized research costs

 

 

11,896

 

 

 

 

Disallowed interest carryforwards

 

 

784

 

 

 

1,580

 

Lease liability

 

 

1,194

 

 

 

1,991

 

Property and equipment

 

 

 

 

 

1,569

 

Share-based compensation

 

 

3,758

 

 

 

4,509

 

Intangible assets

 

 

247

 

 

 

3,371

 

Other

 

 

505

 

 

 

670

 

Subtotal

 

 

41,131

 

 

 

55,044

 

Less: Valuation allowance

 

 

(38,611

)

 

 

(50,956

)

Net deferred tax assets

 

 

2,520

 

 

 

4,088

 

Property and equipment

 

 

(846

)

 

 

 

Operating lease assets

 

 

(1,133

)

 

 

(1,061

)

Prepaid expenses and other assets

 

 

(223

)

 

 

(377

)

Capitalized software development costs

 

 

(318

)

 

 

(2,650

)

Deferred tax liability on foreign investments

 

 

 

 

 

(1,508

)

Net deferred tax liabilities

 

 

(2,520

)

 

 

(5,596

)

Total deferred tax assets (liabilities), net

 

$

 

 

$

(1,508

)

 

 

 

 

 

 

 

Summary of Valuation Allowance on Deferred Tax Assets

For the years ended December 31, 2023 and 2024, the following table reflects the activity in the Company’s valuation allowance on deferred tax assets (in thousands):

 

 

 

Years ended December 31,

 

 

 

2023

 

 

2024

 

 

 

(Restated)

 

 

 

 

Beginning balance

 

$

1,328

 

 

$

38,611

 

Increase in valuation allowance

 

 

37,283

 

 

 

12,345

 

Total valuation allowance on deferred tax assets

 

$

38,611

 

 

$

50,956

 

 

 

 

 

 

 

 

Summary of Gross Income Tax NOL Carryforwards

The Company has gross income tax NOL carryforwards related to its U.S. and international operations.

 

 

Years ended December 31,

 

 

2023

 

 

2024

 

 

(Restated)

 

 

 

Unlimited carryforward

 

$85.9 million

 

 

$151.9 million

10 to 15 year carryforward

 

 

 

 

$1.8 million

20 year carryforward

 

$1.6 million

 

 

$5.1 million

Summary of Tax Credit Carryforwards

The Company has tax credit carryforwards related to research and development.

 

 

Years ended December 31,

 

 

2023

 

 

2024

Unlimited carryforward

 

$2.9 million

 

 

$3.3 million

20 year carryforward

 

 

 

 

$0.9 million

Summary of Gross Corporate Interest Restriction (CIR) Carryforwards

The Company has gross corporate interest restriction (“CIR”) disallowance carryforwards related to its UK operations.

 

 

Years ended December 31,

 

 

2023

 

2024

Unlimited carryforward

 

$3.1 million

 

$6.3 million